Evidence map›Paper›PMID 34676470›Full record

ReviewInsights into imaging2021

Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging.

Ahmed Abdel Khalek Abdel Razek, Ahmed Alksas, Mohamed Shehata, Amr AbdelKhalek, Khaled Abdel Baky, Ayman El-Baz, Eman Helmy

Abstract readReview
In one paragraph

Review in Insights into imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed Abdel Khalek Abdel RazekDepartment of Diagnostic Radiology, Faculty of Medicine, Mansoura University, Elgomheryia Street, Mansoura, 3512, Egypt.
Ahmed AlksasBiomaging Lab, Department of Bioengineering, University of Louisville, Louisville, KY, 40292, USA.
Mohamed ShehataBiomaging Lab, Department of Bioengineering, University of Louisville, Louisville, KY, 40292, USA.
Amr AbdelKhalekInternship at Mansoura University Hospital, Mansoura Faculty of Medicine, Mansoura, Egypt.
Khaled Abdel BakyDepartment of Diagnostic Radiology, Faculty of Medicine, Port Said University, Port Said, Egypt.
Ayman El-BazBiomaging Lab, Department of Bioengineering, University of Louisville, Louisville, KY, 40292, USA.
Eman HelmyDepartment of Diagnostic Radiology, Faculty of Medicine, Mansoura University, Elgomheryia Street, Mansoura, 3512, Egypt. emanata_1978@yahoo.com.ORCID http://orcid.org/0000-0001-5616-0693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is a comprehensive review of the basic background, technique, and clinical applications of artificial intelligence (AI) and radiomics in the field of neuro-oncology. A variety of AI and radiomics utilized conventional and advanced techniques to differentiate brain tumors from non-neoplastic lesions such as inflammatory and demyelinating brain lesions. It is used in the diagnosis of gliomas and discrimination of gliomas from lymphomas and metastasis. Also, semiautomated and automated tumor segmentation has been developed for radiotherapy planning and follow-up. It has a role in the grading, prediction of treatment response, and prognosis of gliomas. Radiogenomics allowed the connection of the imaging phenotype of the tumor to its molecular environment. In addition, AI is applied for the assessment of extra-axial brain tumors and pediatric tumors with high performance in tumor detection, classification, and stratification of patient's prognoses.

Indexed as

Artificial intelligenceDeep learningGliomaMachine learningRadiomics

Identifiers

PMID34676470
PMCPMC8531173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.